Adage Capital Partners Gp, L.L.C. Intra Cellular Therapies, Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

$54.6 Billion
Q3 2024

A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 185,000 shares of ITCI stock, worth $17.6 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

185,000

Previous 501,173 63.09%

Holding current value

$17.6 Million

Previous $34.3 Million 60.59%

% of portfolio

0.02%

Previous 0.07%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$67.99 - $80.84 $21.5 Million - $25.6 Million	-316,173 Reduced 63.09%	185,000 $13.5 Million
Q2 2024 Aug 14, 2024	SELL	$64.76 - $79.84 $3.81 Million - $4.7 Million	-58,827 Reduced 10.5%	501,173 $34.3 Million
Q1 2024 May 15, 2024	BUY	$64.37 - $75.65 $18.3 Million - $21.6 Million	285,000 Added 103.64%	560,000 $38.8 Million
Q4 2023 Feb 14, 2024	SELL	$46.37 - $73.65 $28.3 Million - $44.9 Million	-610,000 Reduced 68.93%	275,000 $19.7 Million
Q3 2023 Nov 14, 2023	BUY	$52.09 - $64.1 $21.1 Million - $26 Million	405,000 Added 84.38%	885,000 $46.1 Million
Q2 2023 Aug 14, 2023	BUY	$54.67 - $66.44 $6.29 Million - $7.64 Million	115,000 Added 31.51%	480,000 $30.4 Million
Q1 2023 May 15, 2023	BUY	$43.8 - $56.99 $16 Million - $20.8 Million	365,000 New	365,000 $19.8 Million
Q3 2022 Nov 14, 2022	SELL	$42.7 - $59.99 $29.8 Million - $41.9 Million	-698,271 Reduced 69.6%	305,000 $14.2 Million
Q2 2022 Aug 15, 2022	BUY	$43.0 - $65.64 $6.59 Million - $10.1 Million	153,271 Added 18.03%	1,003,271 $57.3 Million
Q1 2022 May 16, 2022	BUY	$38.74 - $62.09 $23.2 Million - $37.3 Million	600,000 Added 240.0%	850,000 $52 Million
Q4 2021 Feb 14, 2022	SELL	$35.2 - $53.42 $1.76 Million - $2.67 Million	-50,000 Reduced 16.67%	250,000 $13.1 Million
Q3 2021 Nov 15, 2021	SELL	$28.72 - $42.49 $8.62 Million - $12.7 Million	-300,000 Reduced 50.0%	300,000 $11.2 Million
Q2 2021 Aug 16, 2021	SELL	$29.3 - $44.5 $5.86 Million - $8.9 Million	-200,000 Reduced 25.0%	600,000 $24.5 Million
Q1 2021 May 17, 2021	BUY	$30.8 - $39.51 $1.16 Million - $1.48 Million	37,583 Added 4.93%	800,000 $27.1 Million
Q4 2020 Feb 16, 2021	BUY	$23.34 - $32.22 $8.46 Million - $11.7 Million	362,417 Added 90.6%	762,417 $24.2 Million
Q3 2020 Nov 16, 2020	BUY	$17.61 - $31.86 $7.04 Million - $12.7 Million	400,000 New	400,000 $10.3 Million

Others Institutions Holding ITCI

# of Institutions

379

Shares Held

84.1M

Call Options Held

319K

Put Options Held

143K

View Full List

About Intra-Cellular Therapies, Inc.

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $8.96B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

More about ITCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.

Account

Adage Capital Partners Gp, L.L.C. Intra Cellular Therapies, Inc. Transaction History